Valuation APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 2026-06-16			5-day change	1st Jan Change
1,845.00 ^KRW	-1.70%		+1.10%	-63.10%

05-25	Aprogen Biologics Inc. announced that it expects to receive KRW 50.8 billion in funding from APTOCROM Inc.	CI
05-14	APTOCROM Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	132,471	125,151	66,950	51,548	104,593	55,189
Change	-	-5.53%	-46.5%	-23.01%	102.9%	-47.23%
Enterprise Value (EV) ¹	101,306	69,004	-14,380	55,057	79,526	37,996
Change	-	-31.89%	-120.84%	482.87%	44.44%	-52.22%
P/E Ratio	12x	47.2x	-11.9x	24x	-2.12x	-9.5x
PBR	0.57x	0.56x	0.34x	0.31x	0.35x	0.18x
PEG	-	-0.6x	0x	-0x	0x	0.1x
Capitalization / Revenue	12.8x	14.9x	6.98x	3.22x	6.38x	5.63x
EV / Revenue	9.82x	8.2x	-1.5x	3.44x	4.85x	3.87x
EV / EBITDA	4,671x	-31.8x	1.22x	-2.69x	83.9x	-2.32x
EV / EBIT	-270x	-26.8x	1.19x	-2.62x	154x	-2.27x
EV / FCF	-1.98x	5.77x	-0.46x	13.1x	-32.9x	-1.9x
FCF Yield	-50.6%	17.3%	-216%	7.65%	-3.04%	-52.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	6,200	1,484	-3,140	648.5	-4,924	-526.5
Distribution rate	-	-	-	-	-	-
Net sales ¹	10,319	8,416	9,598	16,007	16,400	9,807
EBITDA ¹	21.69	-2,167	-11,810	-20,454	947.7	-16,372
EBIT ¹	-375.2	-2,579	-12,099	-21,004	517.3	-16,737
Net income ¹	11,084	2,650	-5,607	4,304	-28,094	-5,559
Net Debt ¹	-31,165	-56,147	-81,330	3,509	-25,067	-17,192
Reference price ²	74,200.00	70,100.00	37,500.00	15,580.00	10,420.00	5,000.00
Nbr of stocks (in thousands)	1,785	1,785	1,785	3,309	10,038	11,038
Announcement Date	3/15/21	3/14/22	3/17/23	3/13/24	3/14/25	3/20/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
APTOCROM INC.	-	-	-	-	13.7M
ELI LILLY AND COMPANY	33.05x	12.01x	24.74x	0.6%	1,007B
JOHNSON & JOHNSON	25.19x	5.81x	15.79x	2.26%	567B
ABBVIE INC.	27.13x	6.62x	13.53x	3.1%	392B
ROCHE HOLDING AG	17.5x	4.32x	10.61x	3.07%	328B
NOVARTIS AG	20.98x	5.43x	13.17x	2.95%	277B
ASTRAZENECA PLC	22.23x	4.65x	13.18x	1.88%	275B
NOVO NORDISK A/S	12.63x	4.73x	9.67x	3.97%	196B
AMGEN INC.	22.79x	6.1x	10.65x	2.88%	189B
GILEAD SCIENCES, INC.	-44.54x	5.38x	29.66x	2.61%	154B
Average	15.22x	6.12x	15.67x	2.59%	338.61B
Weighted average by Cap.	22.38x	7.41x	17.25x	2.12%